ArticleInquiry : a journal of medical care organization, provision and financing
National and Subnational Burden of Cholera in Ethiopia, 2019 to 2023: Findings From the Global Burden of Diseases Study 2023.
Article in Inquiry : a journal of medical care organization, provision and financing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cholera remains a significant public health concern in Ethiopia, where recurrent epidemics have been reported for centuries. Despite the launch of the National Cholera Elimination Plan (NCP) aiming to eliminate cholera by 2028, the disease continues to cause substantial morbidity and mortality. This study assessed the national and subnational burden of cholera in Ethiopia from 2019 to 2023 using the Global Burden of Diseases (GBD 2023) estimates. A secondary analysis of GBD 2023 data was conducted to describe temporal trends in cholera mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs) in Ethiopia between 2019 and 2023. The Cause of Death Ensemble model (CODEm) was used to estimate cause-specific mortality, and DisMod-MR 2.1 was used to model non-fatal outcomes. SPSS version 27 was used for the analyses. Nationally, cholera-related deaths decreased from 1.42 (UI: 0.40-3.70) to 1.10 (UI: 0.26-3.22). Total YLLs decreased from 116 593 (UI: 34 140-295 170) to 87 513 (UI: 20 036-244 597), while YLDs declined modestly from 192 (UI: 118-298) to 160 (UI: 97-250). YLLs consistently accounted for more than 99% of total DALYs. Mortality was higher among adults aged ≥50 years, whereas deaths among children under 5 declined. The national Case Fatality Rate (CFR) reached 3.13% in 2022, exceeding the World Health Organization (WHO) threshold of 1%. Subnational analysis of the Amhara region revealed that while deaths and YLLs declined, a 26.7% increase in YLDs led to a net 5.9% rise in DALYs. Cholera remains endemic in Ethiopia, with a gradually decreasing burden over the last 5 years. To achieve the 2028 elimination goal, Ethiopia must strengthen multi-sectoral coordination, scale up sustainable Water, Sanitation, and Hygiene (WaSH) interventions, expand oral cholera vaccine coverage, and reinforce surveillance and health system response capacities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.